Observing health issues faced by travelers
Official title: Observational Study of Travellers Pathologies
Run by Institut Pasteur · NCT06701890 · Data updated 2026-11-12
This study is trying to find out how often travelers get sick when visiting emerging countries and what factors might increase their risk, so we can give better advice to help keep them healthy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 11000 (estimated) |
| Sponsor | Institut Pasteur Industry-sponsored |
| Locations | 1 site (Paris) |
| Status | Recruiting |
| Started | December 9, 2024 |
| Main results expected | December 2034 |
| Study ends | December 2036 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT06701890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are preparing to travel outside mainland France and have a smartphone for data collection.
✕Probably not a fit
Patients traveling for less than 3 days or more than 12 months, or those unable to provide consent, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify the incidence of travel-related illnesses among individuals traveling to emerging countries. It focuses on understanding the behavioral, geographical, and environmental risk factors associated with these health issues, including gastrointestinal and respiratory infections, malaria, and road traffic accidents. The study includes two sub-studies: EOP-Arbo, which investigates the risk of arboviral diseases through blood sample collection, and EOP-AMR, which examines antibiotic-resistant bacteria through fecal sample collection. The findings will help develop targeted recommendations to minimize health risks for travelers.
Why it matters
Potential benefit: If successful, this study could lead to improved health recommendations for travelers, reducing the incidence of travel-related illnesses.
How similar studies have gone: Other studies have shown success in identifying travel-related health risks, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Inclusion Criteria :
1. For all participants in the EOP study :
* Major subject (age ≥ 18)
* Owns a smartphone compatible with electronic data collection
* Preparing to travel outside mainland France
* Affiliated with or covered by Social Security or private insurance
* Willing to participate in the EOP study
2. For the EOP-Arbo Sub-study :
\- Subject who has consented to participate in the EOP\_Arbo study.
3. For the EOP-AMR Sub-study :
* Subject who has consented to participate in the EOP\_AMR study.
2. Exclusion Criteria:
1. For all participants in the EOP study :
* Travel duration ≤ 3 days
* Travel duration \> 12 months
* Person traveling as part of an expatriation without planned movement outside the settlement in the destination country
* Person under legal protection or unable to express consent for participation
2. For the EOP-Arbo Sub-study :
\- Individuals deemed clinically and/or biologically unfit by the investigator to undergo the blood samples required for the study.
3. For the EOP-AMR Sub-study :
* No specific exclusion criteria.
Where it's running
-
Medical Center of Institut Pasteur
Paris, France Recruiting
Study contacts
- Principal investigator: Fabien TAIEB, MD — Medical Center of Institut Pasteur
- Study coordinator: Fabien TAIEB, MD
- Email: fabien.taieb@pasteur.fr
- Phone: 0140613456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MOPEVAC-Las vaccine in healthy adults to test safety and immune response for Lassa fever
A small study in healthy adults checks if MOPEVAC-Las is safe and can trigger an immune response, trying different dose levels.
-
Testing for viruses after a monkey bite
We will test adults who were recently bitten by a monkey or who have a history of monkey bites to see if they carry simian viruses such as STLV-1 or SFV using blood and saliva samples.
-
Speech therapy to improve lip-reading for people who use hearing aids
This will see if speech therapy for lip-reading improves visual speech recognition in adults with moderate-to-severe hearing loss who wear hearing aids.
-
How breast milk affects virus infectivity and transmission
This project will test whether components of donated breast milk change how viruses such as HTLV-1, Zika, dengue, yellow fever, and tick-borne encephalitis infect cells and could affect transmission.
-
Exploring immune responses to yellow fever vaccination
This study is testing whether yellow fever and typhoid vaccines can boost the immune system's ability to fight off other infections, and it involves collecting blood samples from participants after they get vaccinated.
-
Comparing yellow fever vaccination effects during and outside of pregnancy
This study tests how well the yellow fever vaccine works and how safe it is for pregnant women compared to those who are not pregnant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.